Literature DB >> 3994778

Cerebral macroaneurysms in a Ghanaian adult population. An autopsy study.

J T Anim.   

Abstract

An autopsy study of cerebral vessels in 310 Ghanaian adults showed an incidence of macro(berry)aneurysms of 16.6% among 181 hypertensives and 8.5% among 129 normotensives. Hypertension increased the formation and development of intracranial aneurysms. Severe atherosclerosis (Grade 3) was not a common association with aneurysms and there was no increase in aneurysm formation in subjects dying from cerebral haemorrhage. This may be a reflection of the observed low incidence of severe cerebral atherosclerosis in Ghanaians compared to whites and an indication of differences between ethnic groups in the relative importance of the factors that contribute to the formation of aneurysms. Mortality from ruptured aneurysms could not be determined from this study, perhaps because the aneurysms seen were small in size (less than 10 mm diameter) and less likely to rupture and bleed. Multiple aneurysms were an uncommon finding compared to figures quoted in other studies, but in agreement with them the sites of predilection were in the anterior parts of the Circle of Willis; notably the anterior cerebral and anterior communicating arteries.

Entities:  

Mesh:

Year:  1985        PMID: 3994778     DOI: 10.1016/0021-9150(85)90151-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

Review 1.  Prevalence of cerebral aneurysms in autopsy studies: a review of the literature.

Authors:  Tetsuji Inagawa
Journal:  Neurosurg Rev       Date:  2022-04-22       Impact factor: 2.800

Review 2.  A study of autopsy procedures in Ghana: implications for the use of autopsy data in epidemiological analyses.

Authors:  Julius N Fobil; Robert Kumoji; Henry B Armah; Eunice Aryee; Francis Bilson; Derick Carboo; Frederick K Rodrigues; Christian G Meyer; Juergen May; Alexander Kraemer
Journal:  J Public Health Afr       Date:  2011-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.